Clinical trial
PrOgnostic Implications of PRe-stent Pullback Pressure GradIent and Post-stent Quantitative Flow Ratio in Patients UnderGoing Percutaneous Coronary INtervention
NCT05104580 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PrOgnostic Implications of PRe-stent Pullback Pressure GradIent and Post-stent Quantitative Flow Ratio in Patients UnderGoing Percutaneous Coronary INtervention
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 30, 2021
- Completion date
- March 1, 2022
- Enrollment
- 1,395 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.